Key result
Complete absence of NPRA in mice causes hypertension, cardiac hypertrophy, and sudden death before 6 months of age in 100% of males (15/15) and 6.25% of females (1/16).
Why the study?
Does the absence of NPRA cause hypertension, cardiac hypertrophy, and sudden death in mice?
Does the absence of NPRA cause hypertension, cardiac hypertrophy, and sudden death in mice?
Answers are grounded in this paper and cite their sources.
Complete absence of NPRA in mice causes systemic hypertension, cardiac hypertrophy, and lethal vascular events, particularly in males, resembling untreated human hypertensive heart disease.
Natriuretic peptides, produced in the heart, bind to the natriuretic peptide receptor A (NPRA) and cause vasodilation and natriuresis important in the regulation of blood pressure. We here report that mice lacking a functional Npr1 gene coding for NPRA have elevated blood pressures and hearts exhibiting marked hypertrophy with interstitial fibrosis resembling that seen in human hypertensive heart disease. Echocardiographic evaluation of the mice demonstrated a compensated state of systemic hypertension in which cardiac hypertrophy and dilatation are evident but with no reduction in ventricular performance. Nevertheless, sudden death, with morphologic evidence indicative in some animals of congestive heart failure and in others of aortic dissection, occurred in all 15 male mice lacking Npr1 before 6 months of age, and in one of 16 females in our study. Thus complete absence of NPRA causes hypertension in mice and leads to cardiac hypertrophy and, particularly in males, lethal vascular events similar to those seen in untreated human hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Reddick et al. (2020) studied Hypertension and cardiac hypertrophy (n=31). Lack of functional Npr1 gene (NPRA deficiency) was evaluated on Sudden death. Complete absence of NPRA in mice causes hypertension, cardiac hypertrophy, and sudden death before 6 months of age in 100% of males (15/15) and 6.25% of females (1/16).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: